Iberogast®-Induced Acute Liver Injury—A Case Report
Authors:
- Alice LeroyALAlice Leroy
- Henri PerrinHPHenri Perrin
- Raphael PorretRPRaphael Porret
- Christine SempouxCSChristine Sempoux
- Haithem ChtiouiHCHaithem Chtioui
- Montserrat FragaMFMontserrat Fraga
- Pierre-Alexandre BartPBPierre-Alexandre Bart
Open Access
- 19 May 2022
- journal article
- Published by Elsevier in Gastro Hep Advances
- Vol. 1 (4) , 601-603
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Iberogast-Induced Severe Hepatotoxicity Leading to Liver TransplantationAmerican Journal of Gastroenterology, 2016
- Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasisNature Communications, 2016
- Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkHepatology, 2014
- STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disordersWiener Medizinische Wochenschrift, 2012
- Greater Celandine hepatotoxicity: a clinical reviewAnnals of Hepatology, 2012
- Risk Factors for Idiosyncratic Drug-Induced Liver InjuryGastroenterology, 2010
- Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injuryPharmacogenetics and Genomics, 2007
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Meta‐analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast)Alimentary Pharmacology & Therapeutics, 2004
- A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasisNature Genetics, 1998